Physician profile
Tracey S Bertram
NPI 1720428592
$4,762.38
in general payments reported to CMS, 2019-2025
38 companies · $1,265 in 2025
The $1,265 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $72.26 · 2021: $121 · 2022: $1,017 · 2023: $1,269 · 2024: $829 · 2025: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,362.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,160.52 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Novo Nordisk INC | $680.67 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $358.72 | 2019-2025 | |
| Glaxosmithkline, LLC. | $358.27 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $268.58 | 2020-2025 | Mounjaro, Jardiance, Kisunla |
| Amgen INC. | $201.48 | 2019-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $177.60 | 2022-2025 | Airsupra, Breztri |
| Sanofi-Aventis U.S. LLC | $167.38 | 2019-2024 | |
| Medtronic, INC. | $100.15 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Abbott Laboratories | $78.29 | 2022-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $77.04 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $76.30 | 2024-2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $75.67 | 2022-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $75.15 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.13 | 2022-2025 | Xifaxan |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Bertram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.